● Recruiting

Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors

Condition: Neuroendocrine Tumors · Sponsor: Peking Union Medical College Hospital

PhasePhase 1/Phase 2

Planned participants80

Who can joinAll sexes, 18 Years to 80 Years

Healthy volunteersNo

About this study

This prospective, single-center, double-blinded study investigates the biodistribution, dosimetry, safety, and diagnostic ability of Al18F-NOTA-LM3 in patients with well-differentiated neuroendocrine tumors. And compares the diagnostic ability of Al18F-NOTA-LM3 with 68Ga-DOTATATE PET/CT and 68Ga-NODAGA-LM3 PET/CT. Clinical management will also be compared using different imaging modalities.

This description comes directly from the study's public registry record.

Talk to the study team

Meixi Liu, MD · +86-15010405355 · meixiliu_pumc@126.com

Li Huo, MD · +86-13910801986 · huoli@pumch.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Peking Union Medical College Hospital

Beijing, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06056362